R. Andrew Eckert - 26 May 2026 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Reporting relationship: Director
Issuer ticker: MRVI
Reported as of: 26 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 May 2026, 18:26:35 UTC
Prior SEC filing: 29 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ by Kurt Oreshack, by power of attorney for R. Andrew Eckert

Key filing fact

R. Andrew Eckert filed Form 4 for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) on 28 May 2026.

Key facts

This page summarizes R. Andrew Eckert's Form 4 filing for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 May 2026, 18:26.

Change

Previous filing in this sequence was filed on 29 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001210525 Primary reporting owner

ECKERT R ANDREW

Relationship: Director
Address: C/O MARAVAI LIFESCIENCES HOLDINGS, INC., 10770 WATERIDGE CIR., SUITE 200, SAN DIEGO
Signature: /s/ by Kurt Oreshack, by power of attorney for R. Andrew Eckert
Signature date: 28 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRVI transaction

Class A Common Stock

Award

Transaction value
Shares: +46,293
Change %: +13%
Price: $0.000000^*
Shares after: 412,183
Date: 26 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders.